Results 141 to 150 of about 8,424 (263)

PCV9: COST-EFFECTIVENESS OF EPTIFIBATIDE IN THE UK BASED ON PURSUIT TRIAL

, 2001
RE Brown, John Hutton, Raymond Henderson
openalex   +1 more source

Lytic resistance of fibrin containing red blood cells [PDF]

, 2011
Kolev, Kraszimir Nikolaev, Machovich, Raymund, Szabó, László, Sótonyi, Péter, Tenekedjiev, Kiril, Wohner, Nikolett   +5 more
core   +1 more source

Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial [PDF]

, 2005
Uwe Zeymer, Ralf Zahn, Rudolf Schiele, W Jansen, Ernst Girth, Anselm Gitt, Karlheinz Seidl, Rolf Schröder, Steffen Schneider, Jochen Senges   +9 more
openalex   +1 more source

Corrections to “An Optimized Safe Process from Bench to Pilot cGMP Production of API Eptifibatide Using a Multigram-Scale Microwave-Assisted Solid-Phase Peptide Synthesizer” [PDF]

, 2022
Annunziata D’Ercole, L. Pacini, Giuseppina Sabatino, Matteo Zini, Lorenzo Milli, Francesca Nuti, Arianna Ribecai, Alfredo Paio, Paolo Rovero, Anna Maria Papini   +9 more
openalex   +1 more source

A novel role for the fibrinogen Asn-Gly-Arg (NGR) motif in platelet function. [PDF]

, 2014
The integrin αIIbβ3 on resting platelets can bind to immobilised fibrinogen resulting in platelet spreading and activation but requires activation to bind to soluble fibrinogen. αIIbβ3 is known to interact with the general integrin-recognition motif RGD (
Brennan, Marian, Cox, Dermot, Devocelle, Marc, Kerrigan, Steven W, Lambert, Matthew, McManus, Ciara A, Moriarty, Róisín, Tilley, Thea   +7 more
core   +1 more source

PCV21: COST-EFFECTIVENESS ANALYSIS OF ABCIXIMAB, EPTIFIBATIDE, AND TIROFIBAN IN PATIENTS WITH CORONARY SYNDROMES

, 2001
J Shahriar, JW Shaw, Daniel C. Malone
openalex   +1 more source

Eptifibatide is noninferior to abciximab: implications for clinical practice [PDF]

, 2010
Alexandra King
openalex   +1 more source

Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review

Revista Portuguesa de Cardiologia, 2019
This article reviews the major pharmacologic features of, and clinical evidence on, adjuvant medical therapy in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.
Daniel Caldeira, Hélder Pereira
doaj  

Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa

, 2002
Daniel W. Bougie, Peter R. Wilker, Elizabeth D. Wuitschick, Brian R. Curtis, Mohammad Malik, Stewart Levine, Richard N. Lind, Jaime Pereira, Richard H. Aster   +8 more
openalex   +1 more source

Successful Treatment of a Left Main Thrombus by Intracoronary Eptifibatide Infusion in a 36-Year-Old Patient

Journal of Tehran University Heart Center, 2016
The acute coronary syndrome due to the left main coronary artery (LMCA) thrombosis is a clinically rare and catastrophic event.  We describe a young man (smoker, alcoholic, and drug abuser) with a history of recent surgery and typical chest pain who had ...
Saeed Alipour-Parsa, Elham Farahani
doaj